IRIngersoll Rand

We have begun incorporating AI into our business activities and our product and service offerings. As with many innovations, AI presents risks and challenges that could adversely impact our business. The development, adoption, adoption and use of AI technologies are still in their early stages stages, and ineffective or inadequate AI development development, deployment or deployment governance practices could result in unintended consequences. For example, AI algorithms may be flawed or may be based on datasets that are biased or insufficient. In addition, insufficient datasets, and any disruption or failure in the AI functionality we incorporate into our business activities, products or services could adversely impact our business or result in delays or errors in our offerings. Conversely, any failure to successfully develop and deploy AI in our business activities, products and services could adversely affect our competitiveness (particularly if our competitors successfully deploy AI in their businesses, products and services), and the development and deployment of AI will require additional investment and increase our costs. There also may be real or perceived social harm, unfairness, or other outcomes that undermine public confidence in the use and deployment of AI. Any of the foregoing may result in decreased demand for our products or harm to our business, financial statements or reputation.

We can increase the borrowing availability under the New Revolving Credit Facility by up to $1,000.0 Impairment of other intangible assets was $43.7 million in 2025. In the form second quarter of additional commitments on 2025, $36.1 million was recorded to impair a recently acquired indefinite lived tradename within the terms set forth in Precision and Science Technologies segment. In the New Revolving Credit Facility. Our liquidity requirements are significant primarily due fourth quarter of 2025, $7.6 million was recorded to debt service requirements. impair a tradename that was rationalized and rebranded within the Industrial Technologies and Services segment. See Note 12 “Debt” 8 “Goodwill and Other Intangible Assets” to our audited consolidated financial statements included elsewhere in this Form 10-K for further details.

from the Company’s asbestos-related litigation. The Company had has an insurance recovery receivable for probable asbestos environmental related recoveries of $157.7 $1.7 million as of December 31, 2023, 2025 which was included in “Other assets” in the Condensed Consolidated Balance Sheets. There were no material recoveries received in the years ended December 31, 2025, 2024 and 2023.

The Company tests intangible assets with indefinite lives annually for impairment and whenever events or changes in circumstances indicate that the carrying value may not be recoverable, using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.